Scarcity in unlisted shares is not a marketing concept. It is a structural feature of how private markets work, and it has real consequences for how shares are priced, how quickly they move, and how much access any individual investor actually gets. Unlike listed stocks, where supply is essentially defined by total shares outstanding and anyone with a trading account can buy or sell freely, private company shares exist in a far more restricted environment. Understanding why that scarcity exists, and what shapes it at different stages of a company's life, is worth spending time on before you try to participate in this space.
It is worth being precise here because the word gets used loosely.
Scarcity in unlisted shares does not mean the company has issued very few shares in absolute terms. Most private companies have millions of shares on their cap table. What it means is that the proportion of those shares available to buy on the secondary market at any given point is very small. Often a fraction of a percent of total shares outstanding.
Why? Because the shareholders who hold those shares early employees, angel investors, seed-stage funds are under no obligation to sell. There is no exchange forcing them to list their holdings. No market maker creates liquidity. If they want to hold, they hold. And most of them do.
So when someone wants to buy unlisted shares in a company, they are not shopping in a market with thousands of willing sellers. They are looking for the small subset of holders who are either willing to exit, need liquidity, or are permitted to transact under their shareholder agreement. That pool is often tiny relative to demand, particularly for companies generating any kind of investor interest.
The pricing implications of thin supply are significant and frequently underestimated.
In a liquid market, if you want to pay a price higher than what the asset is fundamentally worth, there are enough sellers to push back more supply comes in, price corrects. Private markets do not self-correct this way. When demand for a particular unlisted stock rises and there are only a handful of willing sellers, the price can move to levels that have very little to do with the company's financial position. It is pure supply and demand, operating in an environment without the stabilising force of abundant supply.
This cuts both ways. It can create genuine opportunity early access to a growing company before public markets price it. But it also creates real risk, particularly for investors who enter at a secondary price that is running well above the last formal funding round valuation simply because someone else wants the stock badly enough to overpay.
The scarcity is real. The price response to that scarcity is not always rational.
Several distinct factors work together to keep the float of available unlisted shares very low.
Lock-in periods and shareholder agreements
Most early investors, seed funds, institutional Series A backers are bound by shareholder agreements that restrict their ability to sell. These agreements exist for legitimate reasons. The company wants stability in its cap table. It does not want its founding investors exiting the moment a secondary buyer shows up. Lock-in periods can range from one year to several, and in some cases shares require company approval before any transfer. So even shareholders who want to sell may not be able to.
ESOP holders with limited liquidity access
Employee stock option programmes are a major source of cap table complexity in private companies. Many employees hold options or shares as part of their compensation, but these are rarely freely transferable. Exercise conditions, vesting cliffs, and transfer restrictions all limit how many of those shares actually reach secondary markets. In some companies, employees hold significant paper wealth that they cannot monetise until an IPO or acquisition. That stock is simply not available, regardless of price.
Founders rarely sell early
Founder shares are often the largest single block on the cap table. And founders selling in secondary transactions before an IPO is still relatively uncommon in Indian private markets, and where it does happen, it is usually small and carefully managed to avoid signalling problems. A founder selling aggressively in the secondary market sends a message that most companies would prefer to avoid sending.
Institutional funds managing portfolio optics
Venture and growth equity funds have their own constraints. Selling secondary before a company reaches maturity can affect relationships with founders and co-investors. It can also affect how a fund's performance looks during its investment period. So even funds that might theoretically want to trim a position often hold rather than sell.
The combined effect of all these constraints is that available supply in secondary markets is structurally limited. It is not an accident and it is not temporary. It is built into how private companies structure ownership from the beginning.
Given how restricted supply is, it is worth understanding what actually creates secondary availability.
Early employees who have been at a company for four or more years and have fully vested their options are often the most active source. They have built up meaningful holdings, they have been waiting a long time for liquidity, and they may not want to wait another three to five years for an IPO. Secondary transactions give them a partial exit without requiring the company to go public.
Angel investors from the earliest rounds sometimes sell portions of their stake as a company matures. Not all of them are patient holders but enough to create occasional availability.
Small secondary funds that took stakes in earlier rounds may sell to rebalance or return capital to their own investors.
And occasionally, existing institutional shareholders may agree to a partial secondary alongside a primary funding round, selling a portion of their holding to a new investor as part of a structured transaction.
What is almost never available in meaningful volume: founder shares, ESOP pools, locked-up institutional stakes, and shares subject to board approval that has not been granted.
The secondary price for unlisted shares is not set by an algorithm. It is set by whoever is willing to transact and at what level they agree.
When a company becomes widely discussed after a strong funding round, after a high-profile product launch, after IPO rumours begin circulating demand increases significantly. But supply does not increase to match it. The same shareholders who were not selling before are still not selling. Maybe a few more become willing to sell at a higher price. But the increase in available shares is modest compared to the increase in buyer interest.
The result is that secondary prices can move sharply on relatively thin volumes. A handful of transactions can set a market reference price that influences what the next buyer is willing to pay. It is not manipulation, it is just how thin markets work.
This is worth understanding before entering. The price you see quoted for unlisted shares is not the same thing as a listed stock's market price. It is a reference point derived from limited transactions, often with significant bid-ask spreads, and it can move without any change in the company's fundamentals.
Before transacting in any unlisted stock, work through this.
First, understand why supply is available. If shares are being offered, ask who is selling and why. An employee seeking partial liquidity after many years of holding is a different situation from a seed fund that has been trying to exit for eighteen months. The reason for availability matters.
Second, check the last formal valuation. The most recent funding round gives you the most credible independently set valuation reference. If the secondary price is significantly above that, you are paying a premium for scarcity. That premium may or may not be justified depending on how close the company is to an IPO or other liquidity event.
Third, assess how much of the cap table is actually floating. If you can access any cap table information, estimate what percentage of shares are subject to restrictions versus potentially available. The lower that float, the more susceptible pricing is to supply-demand imbalances.
Fourth, factor in transfer restrictions. Some unlisted shares require board approval for transfer. If you buy and then need to sell before an IPO, can you? Under what conditions? This affects your own liquidity, not just the company's.
Fifth, think about the catalyst for future liquidity. Scarcity is not a permanent condition. An IPO, a strategic acquisition, or a secondary block sale by institutional investors can all create sudden supply. When that happens, the scarcity premium in the price may disappear quickly.
| Factor | What to Check | Good Sign | Red Flag |
| Source of Supply | Who is selling and why | Long-vested employee or angel exit | Distressed seller or unknown source |
| Transfer Restrictions | Board approval required or free transfer | Free transferability with standard process | Approval required with no clear timeline |
| Cap Table Float | Estimated percentage freely available | Reasonable portion without restrictions | Near-total restriction with minimal float |
| Price vs Last Round | Premium or discount to formal valuation | At or near last round valuation | Significant premium on thin rationale |
| Shareholder Agreement Terms | Lock-in terms, ROFR clauses | Clear, standard terms | Unclear or unusually restrictive clauses |
| Liquidity Catalyst Visibility | IPO timeline or acquisition discussion | Concrete milestones, regulatory activity | Vague or absent liquidity pathway |
| Transaction Volume History | Regularity of secondary trades | Occasional but genuine transactions | No prior secondary activity at all |
| Company Consent | Whether company acknowledges transfer | Cooperative and responsive | Unresponsive or resistant to transfer |
Early-stage company shares are scarce partly because there is simply not much investor awareness. The company is not widely discussed. Secondary markets are thin by default, not because demand is particularly high but because very few people are looking for these shares at all.
Late-stage and Pre-IPO company shares are scarce for the opposite reason. Awareness and demand are high. The company is well-known, the IPO discussion is active, and many investors want access. But supply has not kept pace because the structural restrictions have not gone away if anything, they have become more entrenched as the company approaches a listing and wants to maintain cap table stability.
These are different situations that require different thinking. Early-stage scarcity should prompt the question: is this share scarce because it is genuinely difficult to find, or because nobody is particularly interested? Late-stage scarcity should prompt: am I paying a meaningful premium over fundamental value because of the supply squeeze, and what happens to that premium if the IPO gets delayed?
Scarcity is genuinely advantageous when you are able to access shares at or close to the last formal round valuation in a company that is performing well and has a credible path to an IPO or acquisition. In that scenario, limited secondary supply means you are not being crowded out by a wave of sellers suppressing the price, and your position has room to appreciate as the company continues to progress.
Scarcity works against you when it has already driven secondary prices well above what the business fundamentals justify. In that case, you are essentially paying a liquidity premium for the extra cost of getting access to something hard to get on top of a valuation that may already be full. Both of those things can correct at the same time if the supply constraint eases or market sentiment shifts.
Investors should evaluate carefully and not mistake difficulty of access for quality of investment. The two are not the same.
Supremus Angel works in the Pre-IPO and unlisted shared space, and one practical challenge it addresses is exactly this supply problem. Finding genuine, verifiable availability of unlisted shares in companies worth owning is not straightforward for most investors. The process of locating willing sellers, verifying the authenticity of holdings, and understanding transfer restrictions requires either significant existing networks or structured access to the market.
Supremus Angel provides investors with visibility into available secondary opportunities, background on transaction structures, and context around Pre-IPO developments. That does not eliminate the analytical work investors need to do independently, and it does not change the fundamental risk profile of any particular company. Investment outcomes depend on company performance, valuation discipline, and factors that no platform can predict or guarantee. But for investors trying to participate in a market where information asymmetry is significant, structured access matters.
